To investigate whether these changes in MS NAWM indeed relate to MS lesion pathology, we also analyzed the expression of LPL, EEPD1, and CHI3L1 in mixed active/inactive MS lesions. This evidence concerns the gene CHI3L1 and myeloid sarcoma.